TNFRSF8 and neoplasm: HRS cells overexpress the CD30 molecule and T lymphocytes that are redirected to eliminate CD30+ tumor cells through the expression of a chimeric antigen receptor (CAR) specifically binding the CD30 molecule have the potential to generate a sustained antitumor effect.